查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1200897

日本醫院用品市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Japan Hospital Supplies Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 70 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，日本醫院用品市場的複合年增長率預計為 6.9%。

COVID-19 在早期階段對日本醫院用品市場和整個醫療行業產生了重大影響，大量患者激增導致醫院設備、針頭和注射器短缺。稻田。 例如，根據 NPR 2021 年 2 月的一份報告，日本很難獲得特殊的注射器，以最大限度地增加每個小瓶中使用的 COVID-19 疫苗的注射次數。 有人擔心，即使製造商急於提高產量，也會有數百萬劑疫苗被浪費掉。 然而，在大流行後的情況下，市場正在擴大，未來幾年可能會進一步增長。 支持醫院用品需求的是流行病後日本流行的傳染病、院內感染、手術部位感染等的增加。

合併感染疾病的發病率不斷上升以及公眾對這種情況的認識不斷提高等因素預計將推動日本醫院用品市場的擴張。 例如，根據 2022 年 1 月發表的 Plos One 論文，流行性感冒、咽結膜熱、A 組鏈球菌咽炎、水痘、傳染性紅斑、流行性角結膜炎、肺炎支原體和百日咳在 COVID-19 之前在日本流行。 此外，預計在預測期內，日本與醫院用品相關的競爭對手、產品發布和合作的存在將推動市場增長。 同樣，2021年9月，外交部在台北市上演的10,000台脈搏血氧儀和1,008台氧氣濃縮器將捐贈日本，彰顯政府支持東亞國家稻田的承諾。 此外，隨著人口老齡化加劇，醫院供應市場的需求也在增加。 老年人更容易感染和患病，這有望對日本醫院用品市場產生積極影響。 例如，根據日本統計局的數據，2021年老年人口（65歲及以上）將達到3621萬人，佔總人口的28.9%（即四分之一），創歷史新高。

由於傳染病數量的增加和醫療基礎設施的迅速擴張，日本醫院用品市場在預測期內可能會增長。 然而，許可當局的嚴格監管和家庭護理服務的出現正在抑制市場增長。

日本醫院產品的市場動向

滅菌器和消毒劑市場有望在預測期內實現高速增長

消毒是從無生命物體或表面去除或減少有害微生物的過程。 滅菌會殺死所有微生物並破壞存在於表面、液體、藥物或化合物（例如生物介質）上的各種生物體的孢子。

醫院需要滅菌和消毒產品來防止醫院獲得性感染 (HAI) 等疾病的傳播。 老年人也更容易患慢性病。 因此，日本越來越多的老年人患有慢性病，這將導致住院人數增加。 例如，根據日本統計局 2022 年更新，2060 年 65 歲及以上人口的年齡分佈構成估計為 38.1%。 此外，根據2022年6月在Hindawi發表的一篇論文，上海1485家住院三級醫院的病歷發現，與院內感染相比，大多數患者是院內感染。我來了。 因此，由於日本的院內感染率很高，預計該市場在未來幾年將會增長。

此外，與消毒和滅菌行業相關的政府舉措和資金預計將在預測期內推動市場增長。 例如，2022 年 7 月，日本政府向 GARDP 提供額外資金，以支持其在開發耐藥感染新療法方面的重要工作。 這筆預算預計將支持 GARDP 在院內感染、性傳播感染和新生兒感染治療方面的開發工作。 從 2022 年 4 月到 2023 年 3 月，日本已向 GARDP 捐款超過 180 萬美元。 此外，主要參與者正在實施產品發布、併購等戰略計劃，以在預測期內促進市場增長。 例如，2021年1月，IKEUCHI推出了一款新型霧化裝置“Dry-Fog HIGHNOW (DFH)”，可以快速、輕鬆、有效地進行消毒。 這是一種背包式消毒裝置，使用池內專利的特殊噴嘴噴出平均液滴尺寸為10μm或更小的“幹霧”消毒劑。 傳統的噴霧器產生的霧滴粗大，因此通過用DFH噴灑消毒劑，現在可以確保消毒劑到達甚至難以到達的小縫隙和盲點。

因此，由於醫院獲得性感染的增加、老年人口的增加、消毒產品的推出激增等，預計該行業在預測期內將會增長。

在預測期內，日本醫院用品市場的注射器和針頭細分市場預計將顯著增長

由於需要接種疫苗的傳染病增加、醫療成本上升以及產品發布增加等因素，預計日本醫院供應市場的注射器和針頭將會增長。 例如，根據 NIID Japan 2022 監測更新，2022 年東京報告的結核病例累計為 1,738 例。 傳染病的增加將在預測期內推動注射器和針頭部分的增長，因為疫苗接種的需求將會增加。

此外，預計在預測期內，針頭和注射器銷售和收購方面的產品發布、合作和夥伴關係將推動市場增長。 例如，2021 年 3 月，Terumo Corporation 開發了一種注射器，可從 COVID-19 疫苗瓶中抽取 7 針，而現有註射器為 5 針。 此外，預計研究區域增加免疫接種和疫苗接種將推動注射器和針頭市場的增長。 例如，根據 Our World In Data 2022 年 10 月更新，到 2021 年，日本 95% 的 1 歲以下兒童將接種 BCG 疫苗。

因此，由於傳染病數量的增加以及疫苗接種和疫苗接種計劃的增加，預計注射器和針頭部分在預測期內將出現市場增長。

日本醫院供應市場的競爭對手分析

日本醫院用品市場分散，多家公司在全球和本地開展業務。 日本是發達國家，與其他發達國家也有貿易往來。 因此，世界上大多數公司都進入了日本醫院用品市場。 此外，一些日本本土企業也在醫院用品市場佔有一席之地。 其他全球公司也在提高醫院用品在日本市場的競爭力。 主要參與者包括 3M、Medtronic、Cardinal Health、Boston Scientific Corporation 和 B. Brown SE。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 不斷增長的老年人口和不斷增加的傳染病發病率
    • 醫療保健基礎設施的快速擴張
  • 市場製約因素
    • 嚴格的監管框架
    • 家庭護理服務的出現
  • 波特的五力分析
    • 供應商的議價能力
    • 買方/消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按類型
    • 體檢設備
    • 手術室設備
    • 移動支持和運輸設備
    • 滅菌和消毒用品
    • 醫院一次性用品
    • 注射器/針頭
    • 其他類型

第六章競爭格局

  • 公司簡介
    • 3M
    • B. Braun SE
    • Baxter International
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic
    • GE Healthcare
    • Johnson & Johnson
    • Thermo Fisher Scientific

第7章 市場機會今後動向

簡介目錄
Product Code: 54156

The Japan hospital supplies market is expected to register a CAGR of 6.9% over the forecast period.

COVID-19 significantly impacted the hospital supplies market and the entire healthcare industry in Japan during the initial phases, as the shortage of hospital devices, needles, and syringes led to a problematic situation due to the upsurge of the large patient pool. For instance, as per the February 2021 report by NPR, Japan struggled to obtain special syringes to maximize the number of COVID-19 vaccine shots used from each vial. Even though manufacturers strained to ramp up production rapidly, it still prompts concerns that millions of doses might go to waste. However, in the post-pandemic situation, the market is growing and likely to witness more growth in the coming years. The demand for hospital supplies is supported by increased infectious diseases, hospital-acquired infections, and surgical site infections prevalent in Japan in the post-pandemic era.

The factors, such as increased incidences of communal diseases and growing public awareness about the conditions, will likely increase the Japan hospital supplies market. For instance, according to a Plos One article published in January 2022, influenza, pharyngoconjunctival fever, group A streptococcal pharyngitis, chicken pox, erythema infectiosum, epidemic keratoconjunctivitis, Mycoplasma pneumoniae pneumonia, and pertussis, showed an epidemic in Japan before COVID-19. Furthermore, the presence of competitors, product launches, and collaboration in Japan relating to hospital supplies will likely boost market growth over the forecast period. Similarly, in September 2021, 10,000 pulse oximeters and 1,008 oxygen concentrators were donated to Japan which was staged by the Ministry of Foreign Affairs in Taipei City, underscoring the government's commitment to helping the East Asian country. The hospital supply market demand is also rising due to the increasing geriatric population. As the geriatric population is more prone to infection and diseases, this factor is expected to positively impact Japan's hospital supplies market. For instance, as per the Statistics Bureau of Japan, in 2021, the aged population (65 years old and over) was 36.21 million, constituting 28.9% of the total population (i.e., 1 in every four persons) and marking a high record.

Hence, due to the rise in infectious diseases and rapid expansion of healthcare infrastructure, Japan's hospital supplies market is likely to witness growth over the forecast period. However, stringent regulations by approval authorities and the emergence of homecare services have been restraining the market growth.

Japan Hospital Supplies Market Trends

Sterilization and Disinfectant Products Segment is Expected to Register High Growth in the Forecast Period

Disinfection is the process of eliminating or reducing harmful microorganisms from inanimate objects and surfaces. Sterilization kills all microorganisms, destroying the spores of various organisms on surfaces, in liquids, in medication, or in compounds such as biological culture media.

Sterilization and disinfectant products are necessary for hospitals to prevent the spreading of diseases like hospital-acquired infections (HAI). In addition, the geriatric population is more prone to chronic diseases. Thus, Japan's rising geriatric population that acquires chronic diseases leads to increased hospital admissions. For instance, according to the Japan Statistics Bureau 2022 update, the composition of age distribution above 65 is estimated to be 38.1% by 2060. Moreover, as per the article published in June 2022 in Hindawi, the medical records of the 1,485 hospitalized patients in a tertiary Hospital in Shanghai showed that most of the patients were affected with hospital-acquired infections compared to nosocomial diseases. Hence, the market will likely witness growth in the coming years due to Japan's high prevalence of hospital-acquired infections.

Furthermore, government initiatives and funding relating to the disinfection and sterilization field are anticipated to boost market growth over the forecast period. For instance, in July 2022, the Government of Japan granted additional funding to the GARDP to support its vital work in developing new treatments for drug-resistant infections. The budget is anticipated to support GARDP's work in developing treatments for hospital-acquired infections, sexually transmitted infections, and infections in newborns. Japan provided over USD 1.8 million in funding to GARDP from April 2022 to March 2023. Additionally, key players are implementing strategic plans such as product launches, mergers, and acquisitions to boost market growth over the forecast period. For instance, in January 2021, IKEUCHI launched a new fogging device named Dry-Fog HIGHNOW (DFH) for quick, easy, and effective disinfection. It is a backpack-type disinfection device that sprays a disinfectant solution, "Dry Fog," with a mean droplet size of 10 µm or less using a special nozzle patented by IKEUCHI. Unlike conventional sprayers that produce coarse droplets, spraying a disinfectant solution using DFH makes it possible to thoroughly apply the disinfectant to hard-to-reach small gaps and blind spots.

Thus, due to the rise in hospital-acquired infections, the increase in the geriatric population, and the surge in disinfection product launches, the segment studied is anticipated to witness growth over the forecast period.

Syringes and Needles Segment is Anticipated to Witness a Notable Growth in the Japan Hospital Supplies Market Over the Forecast Period

The syringes and needles segment is anticipated to witness growth in the Japan hospital supplies market owing to the factors such as a rise in infectious diseases that require vaccinations, an increase in healthcare expenditure, and a rise in product launches in Japan. For instance, as per the NIID Japan 2022 surveillance update, 1,738 cumulative cases of tuberculosis were reported in Tokyo in 2022. As the number of infectious diseases increases, the demand for immunization rises, thereby driving the syringes and needles segment growth over the forecast period.

Furthermore, product launches, collaborations, and partnerships regarding the sale and availability of needles and syringes are anticipated to boost market growth over the forecast period. For instance, in March 2021, Terumo Corp. developed a syringe that extracts seven shots from a vial of the COVID-19 vaccine, compared to five shots using existing syringes. Furthermore, the rise in vaccinations and immunization in the studied region is anticipated to promote the growth of the syringes and needles market. For instance, according to Our World In Data October 2022 update, 95% of children under one were immunized with the BCG vaccination in Japan in 2021.

Hence, due to the infectious diseases increase and the increase in vaccination and immunization programs, the syringes and needle segment is anticipated to witness growth in the market over the forecast period.

Japan Hospital Supplies Market Competitor Analysis

The Japanese hospital supplies market is fragmented due to several companies operating globally and regionally. Japan is a developed country and has trade relations with other developed nations. As a result, it enjoys the presence of most of the global players in the Japan hospital supplies market. Moreover, some domestic Japanese companies also have a presence in the hospital supplies market. Other global players have made the Japanese market competitive for hospital supplies. Some significant players include 3M, Medtronic, Cardinal Health, Boston Scientific Corporation, and B. Braun SE, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Incidences of Communicable Diseases
    • 4.2.2 Rapid Expansion of Healthcare Infrastructure
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
    • 4.3.2 Emergence of Home Care Services
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Physical Examination Devices
    • 5.1.2 Operating Room Equipment
    • 5.1.3 Mobility Aids and Transportation Equipment
    • 5.1.4 Sterilization and Disinfectant Products
    • 5.1.5 Disposable Hospital Supplies
    • 5.1.6 Syringes and Needles
    • 5.1.7 Other Types

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 B. Braun SE
    • 6.1.3 Baxter International
    • 6.1.4 Becton Dickinson and Company
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 Cardinal Health
    • 6.1.7 Medtronic
    • 6.1.8 GE Healthcare
    • 6.1.9 Johnson & Johnson
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS